S&P 500   4,269.23 (-0.34%)
DOW   33,663.14 (+0.27%)
QQQ   349.54 (-1.49%)
AAPL   177.97 (-0.69%)
MSFT   324.12 (-2.87%)
META   266.24 (-1.80%)
GOOGL   122.85 (-3.50%)
AMZN   122.36 (-3.36%)
TSLA   226.30 (+2.25%)
NVDA   382.27 (-1.10%)
NIO   7.78 (-1.27%)
BABA   85.40 (-1.50%)
AMD   119.44 (-3.86%)
T   15.91 (+1.53%)
F   13.49 (+4.33%)
MU   67.33 (-0.31%)
CGC   0.73 (-1.69%)
GE   106.53 (+1.01%)
DIS   92.64 (+0.52%)
AMC   4.69 (+1.08%)
PFE   38.83 (+1.20%)
PYPL   64.11 (-1.40%)
NFLX   403.04 (+0.94%)
S&P 500   4,269.23 (-0.34%)
DOW   33,663.14 (+0.27%)
QQQ   349.54 (-1.49%)
AAPL   177.97 (-0.69%)
MSFT   324.12 (-2.87%)
META   266.24 (-1.80%)
GOOGL   122.85 (-3.50%)
AMZN   122.36 (-3.36%)
TSLA   226.30 (+2.25%)
NVDA   382.27 (-1.10%)
NIO   7.78 (-1.27%)
BABA   85.40 (-1.50%)
AMD   119.44 (-3.86%)
T   15.91 (+1.53%)
F   13.49 (+4.33%)
MU   67.33 (-0.31%)
CGC   0.73 (-1.69%)
GE   106.53 (+1.01%)
DIS   92.64 (+0.52%)
AMC   4.69 (+1.08%)
PFE   38.83 (+1.20%)
PYPL   64.11 (-1.40%)
NFLX   403.04 (+0.94%)
S&P 500   4,269.23 (-0.34%)
DOW   33,663.14 (+0.27%)
QQQ   349.54 (-1.49%)
AAPL   177.97 (-0.69%)
MSFT   324.12 (-2.87%)
META   266.24 (-1.80%)
GOOGL   122.85 (-3.50%)
AMZN   122.36 (-3.36%)
TSLA   226.30 (+2.25%)
NVDA   382.27 (-1.10%)
NIO   7.78 (-1.27%)
BABA   85.40 (-1.50%)
AMD   119.44 (-3.86%)
T   15.91 (+1.53%)
F   13.49 (+4.33%)
MU   67.33 (-0.31%)
CGC   0.73 (-1.69%)
GE   106.53 (+1.01%)
DIS   92.64 (+0.52%)
AMC   4.69 (+1.08%)
PFE   38.83 (+1.20%)
PYPL   64.11 (-1.40%)
NFLX   403.04 (+0.94%)
S&P 500   4,269.23 (-0.34%)
DOW   33,663.14 (+0.27%)
QQQ   349.54 (-1.49%)
AAPL   177.97 (-0.69%)
MSFT   324.12 (-2.87%)
META   266.24 (-1.80%)
GOOGL   122.85 (-3.50%)
AMZN   122.36 (-3.36%)
TSLA   226.30 (+2.25%)
NVDA   382.27 (-1.10%)
NIO   7.78 (-1.27%)
BABA   85.40 (-1.50%)
AMD   119.44 (-3.86%)
T   15.91 (+1.53%)
F   13.49 (+4.33%)
MU   67.33 (-0.31%)
CGC   0.73 (-1.69%)
GE   106.53 (+1.01%)
DIS   92.64 (+0.52%)
AMC   4.69 (+1.08%)
PFE   38.83 (+1.20%)
PYPL   64.11 (-1.40%)
NFLX   403.04 (+0.94%)
NASDAQ:OCGN

Ocugen (OCGN) Short Interest Ratio & Short Volume

$0.47
0.00 (-0.11%)
(As of 02:34 PM ET)
Compare
Today's Range
$0.46
$0.49
50-Day Range
$0.45
$0.88
52-Week Range
$0.44
$3.11
Volume
6.43 million shs
Average Volume
6.92 million shs
Market Capitalization
$106.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Ocugen Short Interest Data

Current Short Volume
40,760,000 shares
Previous Short Volume
39,950,000 shares
Change Vs. Previous Month
+2.03%
Dollar Volume Sold Short
$29.92 million
Short Interest Ratio / Days to Cover
6.2
Last Record Date
May 15, 2023
Outstanding Shares
226,430,000 shares
Percentage of Shares Shorted
18.00%
Today's Trading Volume
6,431,587 shares
Average Trading Volume
6,916,786 shares
Today's Volume Vs. Average
93%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ocugen ?

Sign up to receive the latest short interest report for Ocugen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OCGN Short Interest Over Time

OCGN Days to Cover Over Time

OCGN Percentage of Float Shorted Over Time


Ocugen (NASDAQ:OCGN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202340,760,000 shares $29.92 million +2.0%N/A6.2 $0.73
4/30/202339,950,000 shares $28.51 million +6.4%N/A6.4 $0.71
4/15/202337,540,000 shares $30.04 million +1.2%N/A6.1 $0.80
3/31/202337,100,000 shares $31.65 million -27.1%N/A5.5 $0.85
3/15/202350,880,000 shares $46.88 million +2.9%N/A7.5 $0.92
2/28/202349,470,000 shares $49.28 million +4.4%N/A8.6 $1.00
2/15/202347,390,000 shares $52.13 million +5.4%N/A9 $1.10
1/31/202344,970,000 shares $57.11 million +0.9%N/A8.6 $1.27
1/15/202344,590,000 shares $57.97 million +9.7%N/A8.8 $1.30
12/30/202240,650,000 shares $52.85 million +0.3%N/A8.3 $1.30
12/15/202240,530,000 shares $58.77 million +0.5%N/A8.8 $1.45
11/30/202240,350,000 shares $62.95 million -2.8%N/A8.6 $1.56
11/15/202241,530,000 shares $71.43 million -4.0%N/A8.6 $1.72
10/31/202243,270,000 shares $74.42 million +0.1%N/A8.6 $1.72
10/15/202243,210,000 shares $67.41 million -1.3%N/A8.6 $1.56
9/30/202243,790,000 shares $77.95 million +6.6%N/A8.5 $1.78
9/15/202241,080,000 shares $96.95 million -9.4%N/A7.8 $2.36
8/31/202245,340,000 shares $116.98 million -7.6%N/A8.1 $2.58
8/15/202249,070,000 shares $141.32 million -11.9%N/A8.2 $2.88
7/31/202255,700,000 shares $143.71 million +3.3%N/A8.7 $2.58
7/15/202253,940,000 shares $139.17 million -1.1%N/A8.1 $2.58
6/30/202254,540,000 shares $123.81 million -0.3%N/A7.8 $2.27
6/15/202254,690,000 shares $113.76 million -8.4%N/A7.6 $2.08
5/31/202259,720,000 shares $141.54 million +3.2%N/A7.2 $2.37
5/15/202257,850,000 shares $121.49 million -1.3%N/A5.3 $2.10
4/30/202258,600,000 shares $128.33 million +8.7%N/A5.5 $2.19
4/15/202253,910,000 shares $148.79 million -2.4%N/A4.7 $2.76
3/31/202255,230,000 shares $182.26 million +14.7%N/A4.5 $3.30
3/15/202248,140,000 shares $130.46 million -6.1%N/A3.6 $2.71
2/28/202251,290,000 shares $180.54 million -5.9%N/A3.7 $3.52
2/15/202254,510,000 shares $212.59 million -0.8%N/A3.9 $3.90
1/31/202254,940,000 shares $195.04 million +1.2%30.2%3.8 $3.55
1/15/202254,310,000 shares $230.82 million -1.7%27.9%1.9 $4.25
12/31/202155,220,000 shares $251.25 million +1.7%28.4%1.7 $4.55
12/15/202154,300,000 shares $294.31 million +9.8%27.8%1.6 $5.42
11/30/202149,470,000 shares $313.64 million +5.4%25.3%1.5 $6.34
11/15/202146,930,000 shares $389.52 million -14.3%24.1%1.5 $8.30
10/29/202154,770,000 shares $648.48 million -3.9%28.2%1.8 $11.84
10/15/202156,980,000 shares $493.45 million +7.4%29.4%2.9 $8.66
9/30/202153,080,000 shares $381.11 million +0.6%27.4%4 $7.18













OCGN Short Interest - Frequently Asked Questions

What is Ocugen's current short interest?

Short interest is the volume of Ocugen shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 40,760,000 shares of OCGN short. Learn More on Ocugen's current short interest.

What is a good short interest ratio for Ocugen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCGN shares currently have a short interest ratio of 6.0. Learn More on Ocugen's short interest ratio.

Which institutional investors are shorting Ocugen?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocugen: Sculptor Capital LP, Susquehanna International Group LLP, Group One Trading L.P., Cutler Group LLC CA, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Ocugen's short interest increasing or decreasing?

Ocugen saw a increase in short interest in May. As of May 15th, there was short interest totaling 40,760,000 shares, an increase of 2.0% from the previous total of 39,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Ocugen's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Ocugen: Cellectis S.A. (0.57%), Elevation Oncology, Inc. (2.29%), Athira Pharma, Inc. (5.81%), Talaris Therapeutics, Inc. (3.81%), Jounce Therapeutics, Inc. (4.60%), Genenta Science S.p.A. (0.01%), Adverum Biotechnologies, Inc. (1.48%), Brainstorm Cell Therapeutics Inc. (9.52%), JATT Acquisition Corp (0.02%), Cidara Therapeutics, Inc. (2.47%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Ocugen stock?

Short selling OCGN is an investing strategy that aims to generate trading profit from Ocugen as its price is falling. OCGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ocugen?

A short squeeze for Ocugen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OCGN, which in turn drives the price of the stock up even further.

How often is Ocugen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCGN, twice per month. The most recent reporting period available is May, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:OCGN) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -